ҽƽ̨ҽѧ×ÊѶ

×ÊѶÖÐÐÄ>ҽѧ½øÕ¹>Ƥ·ôÐÔ²¡> Æê´øÑª¸Éϸ°ûÓÐÍûÖÎÁÆÒìλÐÔÆ¤·ôÑ×

Æê´øÑª¸Éϸ°ûÓÐÍûÖÎÁÆÒìλÐÔÆ¤·ôÑ×

ÊÕ²Ø
À´Ô´£ºÉúÎï¹È 2016-06-20 14:47

ÒìλÐÔÆ¤·ôÑ×(atopic dermatitis)ÕâÒ»²¡ÃûÊÇÓÉÍßҲ˹(Wise)ºÍËÕ×Ȳ®¸ñ(Sulzberger)ÔÚ1933Äê×îÔçÌá³öµÄ¡£
ÒìλÐÔÆ¤·ôÑ×£¬ÓÖÃûÒìλÐÔʪÕî»òÒÅ´«¹ýÃôÐÔʪÕÊÇÒ»ÖÖÓëÒÅ´«ÓÐÃÜÇйØÏµµÄƤ·ô¼²²¡£¬ÒòÒÅ´«µ¼ÖÂÆ¤·ôÒì³£¶ø·¢Éú²¡±ä£¬»á·´¸´·¢×÷ÇÒɦÑ÷Äѵ±¼´Òì³£Ãô¸Ð£¬ºÃ·¢ÓÚÓ¤Ó×¶ùʱÆÚ£¬Ò²Òò´Ë£¬ÓÐЩÈË»á³ÆÖ®Îª¡°Ó¤¶ùʪÕ¡£
ÒìλÐÔÆ¤·ôÑ×ÊôÓÚÂýÐÔ¡¢¸´·¢ÐÔ¡¢ðþÑ÷ÐÔÆ¤·ô²¡¡£ÒìλÐԵĺ¬Ò壺(1)ÓÐÒ×»¼Ïø´­£¬¹ýÃôÐÔ±ÇÑ×£¬ÊªÕîµÄ¼Ò×åÐÔÇãÏò;(2)¶ÔÒìÖÖµ°°×¹ýÃô;(3)ѪÇåÖÐIGEÖµ¸ß;(4)ѪҺÊÈËáÁ£Ï¸°ûÔö¶à¡£µäÐ͵ÄÒìλÐÔÆ¤·ôÑ׳ýÓÐÌØ¶¨µÄʪÕîÁÙ´²±íÏÖÍ⣬»¹¾ßÓÐÉÏÊöËĸöÌØµã¡£
¿ÆÑ§¼ÒÃǶÔÒìλÐÔÆ¤·ôÑ×µÄÈÏʶÉв»Ò»Ö¡£²¡Òò±È½Ï¸´ÔÓ£¬Ò»°ãÈÏΪÓë¶àÖÖÒò×ÓÈçÒÅ´«¡¢»·¾³µÈÓйء£
ÔÚÒ»ÏîеÄÁÙ´²Ñо¿ÖУ¬À´×Ôº«¹úÊ×¶û´óѧºÍ¸ªÉ½´óѧµÄÑо¿ÈËÔ±Ö¸³öÀûÓÃÀ´×ÔÆê´øÑªµÄ¸Éϸ°û½øÐÐÖÎÁÆ¿ÉÄÜÊÇÒ»ÖÖÓÐЧµÄ·½·¨À´ÖÎÁÆÖÐÖØ¶ÈʪÕî»òÕß˵ÒìλÐÔÆ¤·ôÑס£Ïà¹ØÑо¿½á¹ûÓÚ2016Äê6ÔÂ3ÈÕÔÚÏß·¢±íÔÚStem CellsÆÚ¿¯ÉÏ£¬ÂÛÎıêÌâΪ¡°Clinical Trial of Human Umbilical Cord Blood-derived Stem Cells for the Treatment of Moderate-to-Severe Atopic Dermatitis: Phase I/IIa Studies¡±¡£
ÔÚÕâÏîÁÙ´²ÊÔÑéÖУ¬34Ãû²¡È˱»Ëæ»úµØ·ÖÅä½ÓÊܵͼÁÁ¿»ò¸ß¼ÁÁ¿Æê´øÑª¸Éϸ°ûƤÏÂ×¢Éä¡£ÔÚµÚ12ÖÜ£¬55%½ÓÊܸ߼ÁÁ¿×¢ÉäµÄ²¡È˵ÄʪÕîÃæ»ýÓëÑÏÖØ¶ÈÖ¸Êý(eczema area and severity index, EASI)Ͻµ50%¡£ÒìλÐÔÆ¤·ôÑ×µÄÃâÒßÏà¹Ø±êÖ¾ÎïˮƽҲÏÔÖøÏ½µ¡£

¡°ÕâÏîÑо¿ÊÇÊ×ÏîÑо¿Ö¤Êµ»¼ÓÐÖÐÖØ¶ÈÒìλÐÔÆ¤·ôÑ׵IJ¡È˶ÔÔ´×ÔÆê´øÑªµÄ¸Éϸ°ûÖÎÁÆ×÷³ö·´Ó¦¡±£¬ÂÛÎÄͨÐÅ×÷ÕßTae-Yoon Kim²©Ê¿Ëµ£¬¡°¶Ô²¡È˽øÐе¥Ò»µÄ¸Éϸ°ûÖÎÁƵ¼ÖÂÔÚÕû¸ö12ÖܵÄËæ·ÃÆÚÄÚ¼²²¡Ö¢×´ÏÔÖøºÍ³Ö¾ÃµØ¸ÄÉÆ¡£¡±


°æÈ¨ÉùÃ÷£º±¾ÍøÕ¾ËùÓÐÄÚÈÝ£¬·²×¢Ã÷À´Ô´Îª¡°Ñ°Ò½ÎÊÒ©Íø-Ò½Âö¡±£¬°æÈ¨¾ù¹éѰҽÎÊÒ©ÍøËùÓУ¬»¶Ó­×ªÔØ£¬×ªÔØÇë×¢Ã÷×÷Õߺͳö´¦£¬·ñÔò½«×·¾¿·¨ÂÉÔðÈΡ£±¾Íø×¢Ã÷À´Ô´ÎªÆäËûýÌåµÄÄÚÈÝÎª×ªÔØ£¬°æÈ¨¹éÔ­×÷ÕßËùÓУ¬ÈçÓÐÇÖ·¸°æÈ¨£¬Ç뼰ʱÁªÏµÎÒÃÇ¡£

¹Ø¼ü´Ê£º ¸Éϸ°û Ƥ·ô

Ò½ÓÑÆÀÂÛ£¨0ÈËÆÀÂÛ£©

ÄäÃû·¢±í

ÈÈÃżìË÷£ºÌÇÄò²¡ÉËÒ½»ù²ãÒ½Ôº